Unlocking the Pancreatic Cancer Puzzle: Using Intermediate Cells to Target Treatment

Clin Cancer Res. 2024 Jun 3;30(11):2297-2299. doi: 10.1158/1078-0432.CCR-23-3295.

Abstract

KRT17-high intermediate cell population with elevated CXCL8 expression informed elevated myeloid infiltration status in tumors and associated with protumorigenic signatures in peripheral granulocytes from patients with pancreatic cancer. Furthermore, CXCL8 plasma levels were found to resemble KRT17+/CXCL8+ abundance in tumors, in which higher levels predicted worse patient outcomes. See related article by Carpenter et al., p. 2497.

MeSH terms

  • Biomarkers, Tumor
  • Humans
  • Interleukin-8 / blood
  • Interleukin-8 / metabolism
  • Pancreatic Neoplasms* / drug therapy
  • Pancreatic Neoplasms* / pathology
  • Prognosis
  • Tumor Microenvironment / immunology

Substances

  • Interleukin-8
  • Biomarkers, Tumor